Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration

Angiogenesis

Volumn 17, Issue 4, 2014, Pages 851-866

  Edwards, Sandra S ^a   Zavala, Gabriela ^a   Prieto, Catalina P ^a   Elliott, Matías ^a   Martínez, Samuel ^a   Egaña, Jose T ^b   Bono, María R ^a   Palma, Verónica ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiogenesis and wound healing; Growth factors; Mesenchymal stem cells; Scaffold; Umbilical cord; VEGF A

Indexed keywords

ADAMTS1 PROTEIN; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ENDOSTATIN; FIBROBLAST GROWTH FACTOR 1; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LAP PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NRG1 B1 PROTEIN; PERSEPHIN; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PROLACTIN; SCATTER FACTOR; SERPIN E1 PROTEIN; SERPIN F1 PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A; BIOMATERIAL; CULTURE MEDIUM; PROTEOME;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CELL SURVIVAL; CELL VIABILITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SECRETION; STEM CELL EXPANSION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE SCAFFOLD; WOUND HEALING; ADIPOCYTE; ANIMAL; BAGG ALBINO MOUSE; BONE DEVELOPMENT; CELL PROLIFERATION; CHEMISTRY; CHICKEN; CHORIOALLANTOIS; CRYOPRESERVATION; CULTURE MEDIUM; CYTOLOGY; FLOW CYTOMETRY; INFLAMMATION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REGENERATION; SKIN; UMBILICAL CORD; WHARTON JELLY;

ADIPOCYTES; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; CHICKENS; CHORIOALLANTOIC MEMBRANE; CRYOPRESERVATION; CULTURE MEDIA, CONDITIONED; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; OSTEOGENESIS; PROTEOME; REGENERATION; SKIN; TISSUE ENGINEERING; UMBILICAL CORD; WHARTON JELLY; WOUND HEALING;

EID: 84907593785     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-014-9432-7     Document Type: Article

References (100)

1. Singer A, Clark R (1999) Cutaneous wound healing. N Engl J Med 341:738-746
2. Gottrup F (2004) A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg 187:S38-S43
3. Maxson S, Lopez E, Yoo D, Danilkovitch-Miagkova E, LeRoux M (2012) Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med 1:142-149
4. Mustoe T, O'Shaughnessy K, Kloeters O (2006) Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 117:35-41
5. Fife C, Walker D, Thomson B, Carter M (2007) Limitations of daily living activities in patients with venous stasis ulcers undergoing compression bandaging: problems with the concept of self-bandaging. Wounds 19:255-257
6. Burd A, Chiu T (2005) Allogenic skin in the treatment of burns. Clin Dermatol 23:376-387
7. Grant I, Warwick K, Marshall J, Green C, Martin R (2002) The co-application of sprayed cultured autologous keratinocytes and autologous fibrin sealant in a porcine wound model. Br J Plast Surg 55:219-227
8. Currie L, Martin R, Sharpe JR, James SE (2003) A comparison of keratinocyte cell sprays with and without fibrin glue. Burns 29:677-685
9. Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA (2008) Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 14:631-640
10. Ezquer ME, Ezquer FE, Ricca M, Allers C, Conget P (2011) Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. J Hepatol 55:1112-1120
11. Li Q, Zhou X, Shi Y, Li J, Zheng L, Cui L et al (2013) In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury. PLoS ONE 8:e62363
12. Lee J, Cuddihy MJ, Kotov NA (2008) Three-dimensional cell culture matrices: state of the art. Tissue Eng Part B Rev 14:61-86
13. Macneil S (2008) Biomaterials for tissue engineering of skin. Mater Today 11:26-35
14. Murphy CM, O'Brien FJ (2010) Understanding the effect of mean pore size on cell activity in collagen-glycosaminoglycan scaffolds. Cell Adh Migr 4:377-381
15. Shi C, Li Q, Zhao Y, Chen W, Chen B, Xiao Z et al (2011) Stem-cell-capturing collagen scaffold promotes cardiac tissue regeneration. Biomaterials 32:2508-2515
16. Moiemen NS, Vlachou E, Staiano JJ, Thawy Y, Frame JD (2006) Reconstructive surgery with Integra dermal regeneration template: histologic study, clinical evaluation, and current practice. Plast Reconstr Surg 117:160S-174S
17. Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J et al (1988) Artificial dermis for major burns. Ann Surg 208:313-320
18. Machens H, Berger AC, Mailaender P (2000) Bioartificial skin. Cells Tissues Organs 167:88-94
19. Pham C, Greenwood J, Cleland H, Woodruff P, Maddern G (2007) Bioengineered skin substitutes for the management of burns: a systematic review. Burns 33:946-957
20. Vogt P, Lehnhardt M, Wagner D, Jansen V, Krieg M, Steinau H (1998) Determination of endogenous growth factors in human wound fluid: temporal presence and profiles of secretion. Plast Reconstr Surg 102:117-123
21. Pollins AC, Friedman DB, Nanney LB (2007) Proteomic investigation of human burn wounds by 2D-difference gel electrophoresis and mass spectrometry. J Surg Res 142:143-152
22. Taverna D, Nanney LB, Pollins AC, Sindona G, Caprioli R (2011) Multiplexed molecular descriptors of pressure ulcers defined by imaging mass spectrometry. Wound Repair Regen 19:734-744
23. Zisch AH, Lutolf MP, Ehrbar M, Raeber GP, Rizzi SC, Davies N (2003) Cell-demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth. FASEB J 17:2260-2262
24. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366:1736-1743
25. Wilcke I, Lohmeyer JA, Liu S, Condurache A, Krüger S, Mailänder P, Machens HG (2007) VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. Langenbecks Arch Surg 392:305-314
26. Eming S, Krieg T, Davidson J (2007) Gene therapy and wound healing. Clin Dermatol 25:79-92
27. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585-601
28. Falanga V (2012) Stem cells in tissue repair and regeneration. J Invest Dermatol 132:1538-1541
29. Robson M, Phillips LG, Lawrence WT, Bishop JB, Youngerman JS, Hayward PG et al (1992) The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 216:401-408
30. Mast BA (1996) Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 4:411-420
31. Robson M (1997) The role of growth factors in the healing of chronic wounds. Wound Repair Regen 5:12-17
32. Vogt PM, Thompson S, Andree C, Liu P, Breuing K, Hatzis D et al (1994) Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc Natl Acad Sci USA 91:9307-9311
33. Nomi M, Atala A, Coppi PD, Soker S (2002) Principals of neovascularization for tissue engineering. Mol Aspects Med 23:463-483
34. Park HJ, Yang F, Cho SW (2012) Nonviral delivery of genetic medicine for therapeutic angiogenesis. Adv Drug Deliv Rev 64:40-52
35. Song SH, Lee MO, Lee JS, Jeong HC, Kim HG, Kim WS et al (2012) Genetic modification of human adipose-derived stem cells for promoting wound healing. J Dermatol Sci 66:98-107
36. Kleinheinz J, Jung S, Wermker K, Fischer C, Joos U (2010) Release kinetics of VEGF 165 from a collagen matrix and structural matrix changes in a circulation model. Head Face Med 6:1-7
37. Schultz GS, Davidson JM, Kirsner RS, Herman IM (2011) Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 19:134-148
38. Hocking AM, Gibran NS (2010) Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res 316:2213-2219
39. Wei L, Fraser JL, Lu ZY, Hu X, Yu S (2012) Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis 46:635-645
40. Salem HK, Thiemermann C (2010) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28:585-596
41. Li Q, Yao D, Ma J, Zhu J, Xu X, Ren Y et al (2011) Transplantation of MSCs in combination with netrin-1 improves neoangiogenesis in a rat model of hind limb ischemia. J Surg Res 166:162-169
42. Lim JY, Jeong CH, Jun JA, Kim SM, Ryu CH, Hou Y et al (2011) Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther 2:1-47
43. Sukpat S, Isarasena N, Wongphoom J, Patumraj S (2013) Vasculoprotective effects of combined endothelial progenitor cells and mesenchymal stem cells in diabetic wound care: their potential role in decreasing wound-oxidative stress. Biomed Res Int 1-8
44. Stewart MC, Stewart AA (2011) Mesenchymal stem cells: characteristics, sources, and mechanisms of action. Vet Clin North Am Equine Pract 27:243-261
45. Mouiseddine M, François S, Semont A, Sache A, Allenet B, Mathieu N et al (2007) Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 80(1):S49-S55
46. Pozzi S, Lisini D, Podestà M, Bernardo ME, Sessarego N, Piaggio G et al (2006) Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation. Exp Hematol 34:934-942
47. Rojewski MT, Weber BM, Schrezenmeier H (2008) Phenotypic characterization of mesenchymal stem cells from various tissues. Transfus Med Hemother 35:168-184
48. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I et al (2008) Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26:2865-2874
49. Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403
50. Chen MY, Lie PC, Li ZL, Wei X (2009) Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol 37:629-640
51. Shetty P, Thakur AM, Ravindran G, Viswanathan C (2010) Directed therapeutic angiogenesis by mesenchymal stem cells from umbilical cord matrix in preclinical model of ischemic limb disease. Stem Cell Stud 1(e16):97-104
52. Troyer DL, Weiss ML (2008) Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591-599
53. Hsieh JY, Wang HW, Chang SJ, Liao KH, Lee IH, Lin WS et al (2013) Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS ONE 8:e72604
54. Carvalho MM, Teixeira FG, Reis RL, Sousa N, António J (2011) Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Curr Stem Cell Res Ther 6:221-228
55. Ribeiro CA, Fraga JS, Grãos M, Neves NM, Reis RL, Gimble JM et al (2012) The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Res Ther 3:1-17
56. Burlacu A, Grigorescu G, Rosca AM, Preda MB, Simionescu M (2013) Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. Stem Cells Dev 22:643-653
57. Truong ATN, Kowal-Vern A, Latenser BA, Wiley DE, Walter RJ (2005) Comparison of dermal substitutes in wound healing utilizing a nude mouse model. J Burns Wounds 4:e4
58. Egaña JT, Danner S, Kremer M, Rapoport DH, Lohmeyer JA, Dye JF et al (2009) The use of glandular-derived stem cells to improve vascularization in scaffold-mediated dermal regeneration. Biomaterials 30:5918-5926
59. Egaña JT, Fierro FA, Krüger S, Bornhäuser M, Huss R, Lavandero S, Machens HG (2009) Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. Tissue Eng Part A15:1191-1200
60. Danner S, Kremer M, Petschnik AE, Nagel S, Zhang Z, Hopfner U et al (2012) The use of human sweat gland-derived stem cells for enhancing vascularization during dermal regeneration. J Invest Dermatol 132:1707-1716
61. ®. J Plast Reconstr Aesthet Surg 65:228-234
62. Yao M, Attalla K, Ren Y, French MA, Driver VR (2013) Ease of use, safety, and efficacy of integra bilayer wound matrix in the treatment of diabetic foot ulcers in an outpatient clinical setting. A prospective pilot study. J Am Podiatr Med Assoc 103:274-280
63. Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB (2010) Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS ONE 5:e9016
64. Prieto C, Krause B, Quezada C, San Martin R, Sobrevia L, Casanello P (2011) Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endothelium. Placenta 32:932-940
65. Mosna F, Sensebé L, Krampera M (2010) Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells Dev 19:1449-1470
66. Elsdale T, Bard J (1972) Collagen substrata for studies on cell behavior. J Cell Biol 54:626-637
67. Shohara R, Yamamoto A, Takikawa S, Iwase A, Hibi H, Kikkawa F, Ueda M (2012) Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms. Cytotherapy 14:1171-1181
68. Dunn LK, Gruenloh SK, Dunn BE, Reddy DS, Falck JR, Jacobs ER, Medhora M (2005) Chick chorioallantoic membrane as an in vivo model to study vasoreactivity: characterization of development-dependent hyperemia induced by epoxyeicosatrienoic acids (EETs). Anat Rec A Discov Mol Cell Evol Biol 285:771-780
69. Jones I, Currie L, Martin R (2002) A guide to biological skin substitutes. Br J Plast Surg 55:185-193
70. Böttcher-Haberzeth S, Biedermann T, Reichmann E (2010) Tissue engineering of skin. Burns 36:450-460
71. Wong VW, Gurtner GC (2012) Tissue engineering for the management of chronic wounds: current concepts and future perspectives. Exp Dermatol 21:729-734
72. Wu Y, Chen L, Scott PG, Tredget EE (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25:2648-2659
73. Maharlooei MK, Bagheri M, Solhjou Z, Jahromi BM, Akrami M, Rohani L et al (2011) Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats. Diabetes Res Clin Pract 93:228-234
74. Azari O, Babaei H, Derakhshanfar A, Nematollahi-Mahani SN, Poursahebi R, Moshrefi M (2011) Effects of transplanted mesenchymal stem cells isolated from Wharton's jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation. Vet Res Commun 35:211-222
75. Choi M, Lee HS, Naidansaren P, Kim HK, Cha JH, Ahn HY, Yang PI, Shin JC, Joe YA (2013) Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. Int J Biochem Cell Biol 45:560-570
76. Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y et al (2009) Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259:150-156
77. Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369-3376
78. Lin X, Guo C, Gu L, Deuel T (1993) Site-specific methylation inhibits transcriptional activity of platelet-derived growth factor A-chain promoter. J Biol Chem 268:17334-17340
79. Schneider L, Cammer M, Lehman J, Nielsen S, Guerra C, Veland I et al (2010) Directional cell migration and chemotaxis in wound healing response to PDGF-AA are coordinated by the primary cilium in fibroblasts. Cell Physiol Biochem 25:279-292
80. Shikada Y, Yonemitsu Y, Koga T, Onimaru M, Nakano T, Okano S et al (2005) Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas. Cancer Res 65:7241-7248
81. Kagiwada H, Yashiki T, Ohshima A, Tadokoro M, Nagaya N, Ohgushi H (2008) Human mesenchymal stem cells as a stable source of VEGF-producing cells. J Tissue Eng Regen Med 2:184-189
82. Bao P, Kodra A, Tomic-Canic M, Golinko M, Ehrlich H, Brem H (2008) The role of vascular endothelial growth factor in wound healing. J Surg Res 153:347-358
83. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453:314-321
84. Formigli L, Benvenuti S, Mercatelli R, Quercioli F, Tani A, Mirabella C et al (2012) Dermal matrix scaffold engineered with adult mesenchymal stem cells and platelet-rich plasma as a potential tool for tissue repair and regeneration. J Tissue Eng Regen Med 6:125-134
85. Ponce L, Kleinman H (2003) The Chick Chorioallantoic Membrane as an In Vivo Angiogenesis Model. Curr Protoc Cell Biol Chapter 19:Unit 19.5:22-39
86. Ribatti D, Nico B, Vacca A, Presta M (2006) The gelatin sponge-chorioallantoic membrane assay. Nat Protoc 1:85-91
87. Herbert S, Stainier D (2011) Molecular control of endothelial cell behavior during blood vessel morphogenesis. Nat Rev Mol Cell Biol 12:551-564
88. Stefanini MO, Wu FTH, Mac Gabhann F, Popel AS (2008) A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst Biol 2:1-15
89. Oskowitz A, McFerrin H, Gutschow M, Carter M, Pochampally R (2011) Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res 6:215-225
90. Martínez C, Cornejo VH, Lois P, Ellis T, Solis NP, Wainwright BJ, Palma V (2013) Proliferation of murine midbrain neural stem cells depends upon an endogenous sonic hedgehog (Shh) source. PLoS ONE 8:e65818
91. Landman KA, Cai AQ (2007) Cell proliferation and oxygen diffusion in a vascularising scaffold. Bull Math Biol 69:2405-2428
92. Fraisl P, Mazzone M, Schmidt T, Carmeliet P (2009) Regulation of angiogenesis by oxygen and metabolism. Dev Cell 16:167-179
93. Hass R, Kasper C, Böhm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:1-14
94. Lavrentieva A, Majore I, Kasper C, Hass R (2010) Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal 8:1-9
95. Ma T, Grayson WL, Fröhlich M, Vunjak-Novakovic G (2009) Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol Prog 25:32-42
96. Bizzarri A, Koehler H, Cajlakovic M, Pasic A, Schaupp L, Klimant I, Ribitsch V (2006) Continuous oxygen monitoring in subcutaneous adipose tissue using microdialysis. Anal Chim Acta 573-574:48-56
97. Schäffler A, Büchler C (2007) Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25:818-827
98. Jackson WM, Nesti LJ, Tuan RS (2012) Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med. 1:44-50
99. Miyazaki S, Ishikawa F, Fujikawa T, Nagata S, Yamaguchi K (2004) Intraperitoneal injection of lipopolysaccharide induces dynamic migration of Gr-1high polymorphonuclear neutrophils in the murine abdominal cavity. Clin Diagn Lab Immunol 11:452-457
100. Parekkadan B, Milwid JM (2010) Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87-117